Abstract:Rapid and accurate identification of the bacteria responsible for sepsis is paramount for effective patient care. Molecular diagnostic methods, such as polymerase chain reaction (PCR), encounter challenges in sepsis due to inhibitory compounds in the blood, necessitating their removal for precise analysis. In this study we present an innovative approach that utilizes vancomycin (Van) and allantoin (Al)-conjugated polydopamine (PDA)-coated magnetic nanoparticles (MNPs) for the rapid and automated enrichment of bacteria and their DNA extraction from blood without inducing clumping and aggregation of blood. Al/Van-PDA-MNPs, facilitated by IMS, eliminate the need for preliminary sample treatments, providing a swift and efficient method for bacterial concentration and DNA extraction within an hour. Employing Al/Van-PDA-MNPs within an automated framework has markedly improved our ability to pre-concentrate various Gram-negative and Gram-positive bacteria directly from blood samples. This advancement has effectively reduced the detection threshold to 10 2 colony-forming unit/mL by both PCR and quantitative PCR. The method's expedited processing time, combined with its precision, positions it as a feasible diagnostic tool for diverse healthcare settings, ranging from small clinics to large hospitals. Furthermore, the innovative application of nanoparticles for DNA extraction holds promising potential for advancing sepsis diagnostics, enabling earlier interventions and improving patient outcomes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to quickly and accurately identify the bacteria causing sepsis in the diagnosis of sepsis. Specifically, the paper focuses on the limitations of current molecular diagnostic methods (such as polymerase chain reaction (PCR)) in sepsis detection, mainly due to the influence of inhibitory compounds in blood on these methods. To overcome this challenge, the research proposes an innovative method, using magnetic nanoparticles (MNPs) coated with polydopamine (PDA) coupled with vancomycin (Van) and allantoin (Al) to achieve rapid and automated bacterial enrichment and DNA extraction from blood without causing blood clotting or aggregation. This method not only improves the efficiency of bacterial enrichment but also significantly reduces the limit of detection, thereby increasing the speed and accuracy of sepsis diagnosis. ### Main problems 1. **Rapid and accurate identification of sepsis - causing bacteria**: Current diagnostic methods (such as microbiological blood tests) are time - consuming, taking from 24 hours to several days, while molecular diagnostic methods based on gene amplification are faster but are affected by inhibitory compounds in blood, and their accuracy is affected. 2. **Removal of inhibitory compounds in blood**: Existing commercial nucleic acid extraction kits and automated systems can improve the sensitivity of PCR systems, but they have limitations in removing inhibitory compounds, resulting in insufficient detection sensitivity. 3. **Prevention of aggregation of magnetic nanoparticles**: Traditional silica - coated magnetic nanoparticles are prone to aggregation in blood, affecting their ability to capture bacteria. ### Solutions - **Innovative materials**: Use magnetic nanoparticles coated with polydopamine (PDA) and further couple them with vancomycin (Van) and allantoin (Al) to improve the selectivity and capture efficiency for different types of bacteria (Gram - positive and - negative bacteria). - **Automated system**: Develop an automated magnetic separation system (AMSS) that can handle samples up to 2.5 milliliters, achieving efficient bacterial enrichment and DNA extraction. - **High - sensitivity detection**: Through qPCR detection, the limit of detection of this method is as low as 102 CFU/mL, which is three orders of magnitude higher than that of commercial kits. ### Results - **High - efficiency capture**: Van - PDA - MNPs and Al - PDA - MNPs show high capture efficiencies in both PBS and blood, with capture efficiencies for Gram - positive and - negative bacteria exceeding 75% respectively. - **Low limit of detection**: Through qPCR detection, the limit of detection of this method is as low as 102 CFU/mL, which is suitable for multiple bacterial species. - **Anti - aggregation performance**: PDA - coated magnetic nanoparticles do not aggregate in blood and maintain good dispersibility and capture ability. In conclusion, this research provides a rapid, efficient and automated sepsis diagnosis method, which has broad application prospects, especially in clinical diagnosis and treatment.

Automated sepsis detection with vancomycin- and allantoin-polydopamine magnetic nanoparticles

Bacterial species-identifiable magnetic nanosystems for early sepsis diagnosis and extracorporeal photodynamic blood disinfection.

Nanoparticles-based Culture-free Method for Rapid and Sensitive Detection of Staphylococcus Aureus in Bloodstream Infections

Verification of a method using magnetic bead enrichment and nucleic acid extraction to improve the molecular detection of bacterial contamination in blood components

POCT Detection of Pseudomonas aeruginosa by PGM and Application of Preventing Nosocomial Infection of Bronchoscopy

A Platform for Specific and Sensitive Detection of Target Bacteria by Selective Magnetic Enrichment and a Broad-Spectrum Fluorescent Probe

Ultrasensitive Dual ELONA/SERS-RPA Multiplex Diagnosis of Antimicrobial Resistance

Highly Sensitive and Rapid Detection of Pseudomonas Aeruginosa Based on Magnetic Enrichment and Magnetic Separation.

Rapid Identification of MRSA Directly from Sterile Body Fluids by Co-Magnetic Bead Enrichment and MALDI-TOF Mass Spectrometry

Rapid, direct, visualized and antibody-free bacterial detection with extra species identification and susceptibility evaluation capabilities

Rapid bacterial detection and antibiotic susceptibility testing in whole blood using one-step, high throughput blood digital PCR

Vancomycin-Loaded Furriness Amino Magnetic Nanospheres for Rapid Detection of Gram-Positive Water Bacterial Contamination

Toward Rapid Detection of Viable Bacteria in Whole Blood for Early Sepsis Diagnostics and Susceptibility Testing

3D-Printed Modular Microfluidic Device Enabling Preconcentrating Bacteria and Purifying Bacterial DNA in Blood for Improving the Sensitivity of Molecular Diagnostics

Magnetism-Resolved Separation and Fluorescence Quantification for Near-Simultaneous Detection of Multiple Pathogens.

Development of Integrated Systems for On-Site Infection Detection

Integration of diagnosis and treatment in the detection and kill of S.aureus in the whole blood

Highly sensitive SERS nanoplatform based on aptamer and vancomycin for detection of S. aureus and its clinical application

Highly efficient enrichment and identification of pathogens using a herringbone microfluidic chip and by MALDI-TOF mass spectrometry

Rapid Detection and Identification of Vancomycin-Sensitive Bacteria Using an Electrochemical Apta-Sensor

From Shadows to Spotlight: Enhancing Bacterial DNA Detection in Blood Samples through Cutting-Edge Molecular Pre-Amplification